[HTML][HTML] Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion
We have isolated a highly expressed splice variant mRNA of murine estrogen receptor-beta
(ERbeta), mERbeta2, containing an in-frame 54 nucleotide insertion between exons 5 and 6 …
(ERbeta), mERbeta2, containing an in-frame 54 nucleotide insertion between exons 5 and 6 …
Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion.
S Fitter, K Vandyke, S Gronthos… - Journal of Molecular …, 2012 - europepmc.org
Improved glucose and lipid metabolism is a unique side effect of imatinib therapy in some
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion
S Fitter, K Vandyke, S Gronthos… - Journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Improved glucose and lipid metabolism is a unique side effect of imatinib therapy in some
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion
S Fitter, K Vandyke, S Gronthos, A Zannettino - 2012 - digital.library.adelaide.edu.au
Improved glucose and lipid metabolism is a unique side effect of imatinib therapy in some
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
[PDF][PDF] Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion
S Fitter, K Vandyke, S Gronthos… - Journal of Molecular …, 2012 - academia.edu
Improved glucose and lipid metabolism is a unique side effect of imatinib therapy in some
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
[PDF][PDF] Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion
S Fitter, K Vandyke, S Gronthos… - Journal of Molecular …, 2012 - researchgate.net
Improved glucose and lipid metabolism is a unique side effect of imatinib therapy in some
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion
S Fitter, K Vandyke, S Gronthos, A Zannettino - 2012 - hekyll.services.adelaide.edu.au
Improved glucose and lipid metabolism is a unique side effect of imatinib therapy in some
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
[PDF][PDF] Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion
S Fitter, K Vandyke, S Gronthos… - Journal of Molecular …, 2012 - scholar.archive.org
Improved glucose and lipid metabolism is a unique side effect of imatinib therapy in some
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion
S Fitter, K Vandyke, S Gronthos… - Journal of Molecular …, 2012 - research.sahmri.org.au
Improved glucose and lipid metabolism is a unique side effect of imatinib therapy in some
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …
chronic myeloid leukaemia (CML) patients. We recently reported that plasma levels of …